Teva, Procter & Gamble end OTC venture

Apr 22, 2018

Teva Pharmaceuticals has agreed with Procter & Gamble to terminate the PGT Healthcare partnership that they founded in 2011 to market OTC medicines.

PGT Healthcare had grown into a significant presence in over 50 countries, mainly in Europe and Asia, using market-leading brands such as Vick’s and Ratiopharm. But after nearly seven years of working together, the companies concluded that their priorities and strategies were no longer closely aligned.

Each company will take back its own brand and product assets to re-establish independent OTC businesses.

The separation is planned to take effect July 1, 2018.

Read the press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments